SEC Tracker
Get the app

Spyre Therapeutics SYRE

Spyre Therapeutics (SYRE) reports insider sales.

Heidy King-Jones, insider filing for SYRE

Form
4
Filed
Importance
Routine
  1. Oct 1, 2026: Sold 28,933 shares at $14.50
  2. Oct 1, 2026: Sold 400 shares at $89.24
  3. Oct 1, 2026: Sold 16,605 shares at $90.35
  4. Oct 1, 2026: Sold 7,228 shares at $91.35

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Spyre Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Schrodinger SDGR public float $1.1B, Jun 30, 2025
  2. Mannkind MNKD public float $1.1B, Jun 30, 2025
  3. Novavax NVAX public float $1.0B, Jun 30, 2025
  4. Harrow HROW public float $1.0B, Jun 30, 2025
  5. Aurinia Pharmaceuticals AUPH public float $1.0B, Jun 30, 2025